As part of Connecticut’s continuing crackdown on the sale of bootleg GLP-1 weight loss drugs, Attorney General William Tong announced today that international trade platform Made-in-China will cease all sales of unlawful so-called “research grade” GLP-1s into the United States.

“There are currently no generic GLP-1 weight loss injections on the market, and anyone advertising or offering this is not telling the truth and exposing patients to potentially unsafe bootleg drugs. We will continue to identify and shut down sales of these illegal and unsafe products. Additional enforcement actions are active and ongoing, and we will not hesitate to take strong action to protect patients and consumers,” said AG Tong.